WorldCat Identities

Klug, Stefanie J.

Overview
Works: 24 works in 28 publications in 2 languages and 66 library holdings
Roles: Other, Author, Contributor, dgs, Editor
Publication Timeline
.
Most widely held works by Stefanie J Klug
Untersuchungen zur Interaktion des prokaryotischen Elongationsfaktors SELB mit RNA in vitro und in vivo by Stefanie J Klug( Book )

2 editions published in 1997 in German and held by 10 WorldCat member libraries worldwide

AusTher-Studie Abschlussbericht : Laufzeit: 01.04.2014-31.03.2017 by D Schweigler( )

1 edition published in 2017 in German and held by 6 WorldCat member libraries worldwide

The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program by Anne Neumann( )

2 editions published between 2016 and 2017 in English and held by 3 WorldCat member libraries worldwide

Background: Policymakers need to know the cost-effec-tiveness of interventions to prevent type 2 diabetes (T2D). The objective of this study was to estimate the cost-effectiveness of a T2D prevention initiative targeting weight reduction, increased physical activity and healthier diet in persons in pre-diabetic states by comparing a hypothetical intervention versus no intervention in a Swedish setting. Methods: A Markov model was used to study the cost-effectiveness of a T2D prevention program based on lifestyle change versus a control group where no prevention was applied. Analyses were done deterministically and probabilistically based on Monte Carlo simulation for six different scenarios defined by sex and age groups (30, 50, 70 years). Cost and quality adjusted life year (QALY) differences between no intervention and intervention and incremental cost-effectiveness ratios (ICERs) were estimated and visualized in cost-effectiveness planes (CE planes) and cost-effectiveness acceptability curves (CEA curves). Results: All ICERs were cost-effective and ranged from 3833 € /QALY gained (women, 30 years) to 9215 € /QALY gained (men, 70 years). The CEA curves showed that the probability of the intervention being cost-effective at the threshold value of 50,000 € per QALY gained was very high for all scenarios ranging from 85.0 to 91.1%. Discussion/conclusion: The prevention or the delay of the onset of T2D is feasible and cost-effective. A small investment in healthy lifestyle with change in physical activity and diet together with weight loss are very likely to be cost-effective
Risk equations for the development of worsened glucose status and type 2 diabetes mellitus in a Swedish intervention program by Anne Neumann( )

2 editions published in 2013 in English and held by 3 WorldCat member libraries worldwide

Background: Several studies investigated transitions and risk factors from impaired glucose tolerance (IGT) to type 2 diabetes mellitus (T2D). However, there is a lack of information on the probabilities to transit from normal glucose tolerance (NGT) to different pre-diabetic states and from these states to T2D. The objective of our study is to estimate these risk equations and to quantify the influence of single or combined risk factors on these transition probabilities. Methods: Individuals who participated in the VIP program twice, having the first examination at ages 30, 40 or 50 years of age between 1990 and 1999 and the second examination 10 years later were included in the analysis. Participants were grouped into five groups: NGT, impaired fasting glucose (IFG), IGT, IFG & IGT or T2D. Fourteen potential risk factors for the development of a worse glucose state (pre-diabetes or T2D) were investigated: sex, age, education, perceived health, triglyceride, blood pressure, BMI, smoking, physical activity, snus, alcohol, nutrition and family history. Analysis was conducted in two steps. Firstly, factor analysis was used to find candidate variables; and secondly, logistic regression was employed to quantify the influence of the candidate variables. Bootstrap estimations validated the models. Results: In total, 29 937 individuals were included in the analysis. Alcohol and perceived health were excluded due to the results of the factor analysis and the logistic regression respectively. Six risk equations indicating different impacts of different risk factors on the transition to a worse glucose state were estimated and validated. The impact of each risk factor depended on the starting or ending pre-diabetes state. High levels of triglyceride, hypertension and high BMI were the strongest risk factors to transit to a worsened glucose state. Conclusions: The equations could be used to identify individuals with increased risk to develop any of the three pre-diabetic states or T2D and to adapt prevention strategies
Krankheitslast und Impfprävention HPV-assoziierter Krebserkrankungen by Nina Buttmann-Schweiger( Book )

1 edition published in 2019 in German and held by 3 WorldCat member libraries worldwide

Prevention of cervical cancer guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) : Part 1 with introduction, screening and the pathology of cervical dysplasia = Prävention des Zervixkarzinoms : Leitlinie der DGGG und DKG (S3-Level, AWMF-Register-Nummer 015/027OL, Dezember<br>2017) : Teil 1 mit Einführung, Screening und Pathologie von zervikalen Dysplasien by Peter Hillemanns( )

1 edition published in 2019 in English and held by 3 WorldCat member libraries worldwide

Abstract: Ziele <br>Seit 1971 erfolgt in Deutschland die jährliche, opportunistische Früherkennungsuntersuchung des Zervixkarzinoms. Durch die Etablierung dieser S3-Leitlinie wird zum einen eine wichtige Forderung des Nationalen Krebsplans zum Zervixkarzinom-Screening erfüllt. Zum anderen kann die S3-Leitlinie wesentliche Informationen und Hilfestellungen für das geplante organisierte Zervixkarzinomscreening in Deutschland geben.<br><br>Methoden <br>Mit finanzieller Unterstützung durch die Deutsche Krebshilfe wurden durch 21 Fachgesellschaften evidenzbasierte Statements und Empfehlungen (GRADE-System) zu Screening, Management und Behandlung von Zervixkarzinom-Vorstufen erarbeitet. Zwei unabhängige wissenschaftliche Institute haben systematische Reviews für diese Leitlinie erarbeitet.<br><br>Empfehlungen <br>Der erste Teil dieser Kurzzusammenfassung behandelt pathologische Grundlagen und Fragen zum Screening. Ähnliche wie in früheren Reviews konnte auch die Metaanalyse durch Kleijnen Systematic Reviews einen besseren Schutz vor einem invasiven Zervixkarzinom durch ein HPV-basiertes Screening im Vergleich zur Zytologie zeigen. Daher empfiehlt die Leitliniengruppe - entsprechend den Richtlinien des Gemeinsamen Bundesauschusses (G-BA) - ein HPV-basiertes Screening mit Intervallen von mind. 3 Jahren für Frauen ab 35 Jahren. Ein Co-Testing kann ebenfalls durchgeführt werden. Frauen zwischen 20 und 35 sollten ein zytologisches Screening alle 2 Jahre erhalten
Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011 by Olaf Schoffer( )

2 editions published in 2016 in English and held by 3 WorldCat member libraries worldwide

Humane Papillomaviren (HPV) und Früherkennung des Zervixkarzinoms aus epidemiologischer Sicht by Stefanie J Klug( Book )

1 edition published in 2008 in German and held by 3 WorldCat member libraries worldwide

Prevention of cervical cancer guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) : Part 2 on triage, treatment and follow-up = Prävention des Zervixkarzinoms : Leitlinie der DGGG und DKG (S3-Level, AWMF-Register-Nummer 015/027OL, Dezember 2017) : Teil 2 mit Abklärung, Therapie und Nachbetreuung by Peter Hillemanns( )

1 edition published in 2019 in English and held by 3 WorldCat member libraries worldwide

Abstract: Aims <br>Annual opportunistic screening for cervical carcinoma has been done in Germany since 1971. The creation of this S3 guideline meets an important need, outlined in the National Cancer Plan, with regard to screening for cervical cancer, as this guideline aims to provide important information and support for planned organized screening for cervical cancer in Germany.<br><br>Methods <br>With the financial support of German Cancer Aid, 21 professional societies developed evidence-based statements and recommendations (classified using the GRADE system) for the screening, management and treatment of precancerous conditions of the cervix. Two independent scientific institutes compiled systematic reviews for this guideline.<br><br>Recommendations <br>The second part of this short summary deals with the triage, treatment and follow-up care of cervical dysplasia. With regard to those women who do not participate in screening, the guideline authors recommend sending out repeat invitation letters or an HPV self-collection kit. Colposcopy should be carried out for further investigation if cytology findings are Pap II-p and HPV test results are positive or if the results of an HPV 16 or HPV 18 screening test are positive. A single abnormal Pap smear should be triaged and investigated using HPV testing or p16/Ki67 dual staining
Evaluation of polymorphisms in angiogenesis-related genes as predictive and prognostic markers for sunitinib-treated metastatic renal cell carcinoma patients by Juana Dornbusch( )

1 edition published in 2016 in English and held by 2 WorldCat member libraries worldwide

Association of endothelial dysfunction with incident prediabetes, type 2 diabetes and related traits: the KORA F4/FF4 study by Marie-Theres Huemer( )

1 edition published in 2020 in English and held by 2 WorldCat member libraries worldwide

Meeting abstracts : MAINZ 2011 by Biometrieund Epidemiologie Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik( Book )

1 edition published in 2011 in German and held by 2 WorldCat member libraries worldwide

Die STIKO empfiehlt die HPV-Impfung jetzt auch für Jungen by Ständige Impfkommission (STIKO) und AG HPV der STIKO( )

1 edition published in 2018 in German and held by 2 WorldCat member libraries worldwide

Cancer incidence in Germany attributable to human papillomavirus in 2013 by Nina Buttmann-Schweiger( )

1 edition published in 2017 in English and held by 2 WorldCat member libraries worldwide

Factors influencing uptake of HPV vaccination among girls in Germany by Stefanie Schülein( )

1 edition published in 2016 in English and held by 2 WorldCat member libraries worldwide

Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review by Thomas Harder( )

1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide

Gebärmutterhalskrebsscreening in Deutschland by Janina Bujan Rivera( )

1 edition published in 2018 in German and held by 2 WorldCat member libraries worldwide

Background paper for the recommendation of HPV vaccination for boys in Germany by Anja Takla( )

1 edition published in 2018 in English and held by 2 WorldCat member libraries worldwide

Humane Papillomaviren (HPV): Erreger, Impfung und Praxishinweise( )

1 edition published in 2018 in German and held by 2 WorldCat member libraries worldwide

Aktueller Stand der HPV-Impfung in Deutschland by Yvette Garbe( )

1 edition published in 2017 in German and held by 2 WorldCat member libraries worldwide

 
moreShow More Titles
fewerShow Fewer Titles
Audience Level
0
Audience Level
1
  General Special  
Audience level: 0.95 (from 0.90 for AusTher-St ... to 0.97 for Humane Pap ...)

Alternative Names
Klug, Stefanie Jeanette 1966-

Stefanie J. Klug wetenschapper

Languages
English (14)

German (10)